Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
PLOS ONE, 2021Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Kerzeli I., Lord M., Doroszko M. et al.
Olink Target 96 Mouse
European Journal of Heart Failure, 2021Proteomics to improve phenotyping in obese patients with heart failure with preserved ejection fraction
Kresoja K., Rommel K., Wachter R. et al.
Olink Target 96
Journal of Extracellular Vesicles, 2021Extracellular vesicle‐mediated endothelial apoptosis and EV‐associated proteins correlate with COVID‐19 disease severity
Krishnamachary B., Cook C., Kumar A. et al.
Scientific Reports, 2021Statistical and machine learning methods for analysis of multiplex protein data from a novel proximity extension assay in patients with ST-elevation myocardial infarction
Maag E., Kulasingam A., Grove E. et al.
Nano Select, 2021Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia
Niemeyer B., Miller C., Ledesma‐Feliciano C. et al.
The American Journal of Clinical Nutrition, 2021Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic
Cauwenberghs N., Prunicki M., Sabovčik F. et al.
EP Europace, 2021Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies
De With R., Artola Arita V., Nguyen B. et al.
eClinicalMedicine, 2021Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
Laursen J., Søndergaard-Heinrich N., de Melo J. et al.
Journal of Personalized Medicine, 2021Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
Guldvik I., Ekseth L., Kishan A. et al.
ESC Heart Failure, 2021Identification of sex‐specific biomarkers predicting new‐onset heart failure
Raafs A., Verdonschot J., Ferreira J. et al.
Journal of Cachexia, Sarcopenia and Muscle, 2021Proteomic profiling of low muscle and high fat mass: a machine learning approach in the KORA S4/FF4 study
Huemer M., Bauer A., Petrera A. et al.
Clinical Chemistry and Laboratory Medicine (CCLM), 2021Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay
Fraser D., Chen M., Ren A. et al.
Journal of Allergy and Clinical Immunology, 2021Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications
Abyazi M., Bell K., Gyimesi G. et al.
Journal of the American Society of Nephrology, 2021Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías-García P., Wilson R., Guo Q. et al.
Journal of Cancer Research and Clinical Oncology, 2021Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma
Camargo M., Song M., Ito H. et al.
Nature Communications, 2021The geometry of clinical labs and wellness states from deeply phenotyped humans
Zimmer A., Korem Y., Rappaport N. et al.
Biofabrication, 2021Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells
Drzeniek N., Mazzocchi A., Schlickeiser S. et al.
Science Translational Medicine, 2021Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Reyes M., Filbin M., Bhattacharyya R. et al.
Olink Explore 3072/384
Cell Discovery, 2021Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Tan Y., Zhang W., Zhu Z. et al.
PLOS ONE, 2021Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Kragstrup T., Singh H., Grundberg I. et al.
2846 publications
Items per page
1861-1880 of 2846 publications